AstraZeneca's (AZN) Lynparza Granted Priority Review by the FDA
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- Wall St bounces as oil cools, inflation risks keeps Fed in focus
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but on track for sharp weekly gain on supply concerns; US diesel hits record high
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
2 Reasons Why Citi Downgraded Merck (MRK) to Neutral Today, Opened a Negative Catalyst Watch
November 29, 2021 6:45 AM ESTShares of Merck (NYSE: MRK) are down 1.7% in pre-open Monday after Citi analyst Andrew Baum downgraded to Neutral from Buy with a price target of $85.00 per share from the prior $105.00.
First, the analyst sees a high probability that Merck will terminate islatravir development in the coming months amid strong regulatory... More
JPMorgan Reiterates Overweight Rating on AsztraZeneca PLC (AZN:LN) (AZN)
November 29, 2021 5:33 AM ESTJPMorgan analyst James Gordon reiterated an Overweight rating and GBP100.00 price target on AsztraZeneca PLC (AZN:LN) (NASDAQ: AZN).
... MoreAstraZeneca hopeful its antibody cocktail will work on new COVID variant
November 26, 2021 12:54 PM ESTLONDON (Reuters) - AstraZeneca said on Friday it was hopeful its antibody cocktail against COVID-19 would retain efficacy against a new variant that is spreading in South Africa, and was also examining whether the variant was resistant to its vaccine.
"As with any new emerging variants, we are... More
